Corteva reported second-quarter 2026 net sales of $6.38 billion, down 1% from a year earlier, and GAAP earnings per share from continuing operations of $1.81, down 10%. Non-GAAP operating EBITDA rose 4% to $2.26 billion and operating EPS rose 5% to $2.30, and the company raised its full-year 2026 guidance to operating EBITDA of $4.1 billion to $4.3 billion and operating EPS of $3.60 to $3.80 per share.
Q2 2026 net sales were $6.38 billion, down 1%; organic sales fell 2%
GAAP EPS from continuing operations was $1.81 versus $2.02 in the year-earlier quarter; GAAP income from continuing operations after taxes was $1.22 billion
Full-year 2026 operating EBITDA guidance is $4.1 billion to $4.3 billion; operating EPS guidance is $3.60 to $3.80 per share
The planned separation remains on track for an October 1, 2026 spin-off of Vylor, with an Investor Day on September 15, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Corteva's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$17.40B
+2.9%
$1.60
+23.1%
6.3%
FY2024
$16.91B
-1.8%
$1.30
+26.2%
5.4%
FY2023
$17.23B
-1.3%
$1.03
-34.8%
4.3%
FY2022
$17.45B
+11.5%
$1.58
-33.3%
6.6%
FY2021
$15.65B
+10.1%
$2.37
+160.4%
11.2%
Frequently asked questions
When is Corteva's next earnings date?
Corteva (CTVA) is scheduled to report on Wednesday, November 11, 2026 after the market closes. Analysts expect EPS of $0.09.
What did Corteva earn last quarter?
For the quarter ended Jun 2026, Corteva reported diluted EPS of $1.73 (-9.9% year over year) on revenue of $6.38B (-1.2%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.